Skip to main content

Table 1 Patient characteristics and disease parameters

From: Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system

 

Total axSpA

nr-axSpA(n = 29)

AS(n = 29)

P-value

Age (years)

25.69 ± 6.79

25.00 ± 6.00

27.00 ± 7.40

0.198

Male(n,%)

41(70.69)

18(62.09)

23(79.31)

0.149

HLA-B27(n,%)

33(56.90)

13(44.83)

20(68.97)

0.248

Baseline

 ESR (mm/h)

24.43 ± 23.83

18.60 ± 17.80

30.31 ± 27.70

0.065

 CRP (mg/L)

17.52 ± 29.41

9.33 ± 22.41

25.40 ± 33.41

0.053

 SPARCC

24.79 ± 17.13

22.90 ± 15.23

26.69 ± 18.91

0.602

 SSS

26.93 ± 20.26

14.26 ± 11.70

39.60 ± 19.13

< 0.001

  1. ESR Erythrocyte sedimentation rate, CRP C-reactive protein, SPARCC Spondyloarthritis Research Consortium of Canada, SSS SPARCC Sacroiliac Joint Structural Scores
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us